BioCanRx: Biotherapeutics For Cancer Treatment /BioCanRx: Biothérapies pour le traitement du cancer
$38,009,500.00 CAD
≈ $0.92 for every person in Canada
≈ 491 Canadians' average pay for a year
- Program
- SSF - Science & Research
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- April 1, 2024 – March 31, 2029
- Reference
- ic:033-2024-2025-Q1-515281
Published purpose
BioCanRx was established in 2015 as a federally-funded NCE to develop, manufacture, and clinically test new cancer immunotherapies.
In plain English AI-generated
This federal contribution supports BioCanRx, a network established in 2015 to develop, manufacture, and clinically test new cancer immunotherapies in Canada.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions